CoChat

Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia

Berk, Michael, Munib, Ahmed, Dean, Olivia, Malhi, Gin S., Kohlmann, Kristy, Schapkaitz, Ian, Jeavons, Sue, Katz, Fiona, Anderson-Hunt, Murray, Conus, Philippe, Hanna, Barbara, Otmar, Renée, Ng, Felicity, Copolov, David L., Bush, Ashley I. · 2011 · The Journal of Clinical Psychiatry
Cited by 33

The DOI matches its Crossref record.

Abstract

Article Abstract Objective: The pharmacokinetic profile of a drug often gives little indication of its potential therapeutic application, with many therapeutic uses of drugs being discovered serendipitously while being studied for different indications. As hypothesis-driven, quantitative research methodology is exclusively used in early-phase trials, unexpected but important phenomena may escape detection. In this context, this study aimed to examine the potential for integrating qualitative research methods with quantitative methods in early-phase drug trials. To our knowledge, this mixed methodology has not previously been applied to blinded psychopharmacologic trials. Method: We undertook qualitative data analysis of clinical observations on the dataset of a randomized, double-blind, placebo-controlled trial of N-acetylcysteine (NAC) in patients with DSM-IV-TR-diagnosed schizophrenia (N = 140). Textual data on all participants, deliberately collected for this purpose, were coded using NVivo 2, and emergent themes were analyzed in a blinded manner in the NAC and placebo groups. The trial was conducted from November 2002 to July 2005. Results: The principal findings of the published trial could be replicated using a qualitative methodology. In addition, significant differences between NAC- and placebo-treated participants emerged for positive and affective symptoms, which had not been captured by the rating scales utilized in the quantitative trial. Qualitative data in this study subsequently led to a positive trial of NAC in bipolar disorder. Conclusions: The use of qualitative methods may yield broader data and has the potential to complement traditional quantitative methods and detect unexpected efficacy and safety signals, thereby maximizing the findings of early-phase clinical trial research. Trial Registration: www.anzctr.org.au Identifier: ACTRN12605000363684 J Clin Psychiatry 2011;72(7):909-913 Submitted: September 21, 2009; accepted December 14, 2009. Online ahead of print: September 21, 2010 (doi:10.4088/JCP.09m05741yel). Corresponding author: Michael Berk, MD, PhD, Department of Clinical and Biomedical Sciences: Barwon Health, University of Melbourne, PO Box 281, Geelong 3220, Victoria, Australia (mikebe@barwonhealth.org.au).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.09m05741yel

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 33

Metadata

Authors
Berk, M., Munib, A., Dean, O., Malhi, G. S., Kohlmann, K., Schapkaitz, I., Jeavons, S., Katz, F., Anderson-Hunt, M., Conus, P., Hanna, B., Otmar, R., Ng, F., Copolov, D. L., & Bush, A. I.
Venue
The Journal of Clinical Psychiatry
Published
2010-09-21
Volume
72
Issue
07
Pages
909-913
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2027389464
Cited by
33
References
0
FWCI
1.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia. https://app.cochat.ai/papers/10.4088/jcp.09m05741yel
The paper
Berk, M., Munib, A., Dean, O., Malhi, G. S., Kohlmann, K., Schapkaitz, I., Jeavons, S., Katz, F., Anderson-Hunt, M., Conus, P., Hanna, B., Otmar, R., Ng, F., Copolov, D. L., & Bush, A. I. (2011). Qualitative Methods in Early-Phase Drug Trials: Broadening the Scope of Data and Methods From an RCT of N-Acetylcysteine in Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.09m05741yel

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.